SciSparc's 15min chart shows MACD Death Cross, Bearish Marubozu signal.

SciSparc's 15-minute chart has recently exhibited a MACD Death Cross and a Bearish Marubozu pattern, which occurred on 11th August 2025 at 13:45. This suggests that the stock price may continue to decline, as sellers have gained control of the market and bearish momentum is likely to persist.

SciSparc Ltd.'s stock price has shown signs of potential decline following recent technical indicators. On 11th August 2025 at 13:45, the 15-minute chart exhibited a MACD Death Cross and a Bearish Marubozu pattern. These indicators suggest that sellers have gained control of the market, and bearish momentum is likely to persist. Investors should closely monitor these developments.

SciSparc, a specialty clinical-stage pharmaceutical company, has been making strides in the development of therapies for disorders and rare diseases of the central nervous system. Recently, the company announced a significant milestone in its collaboration with Clearmind Medicine Inc. The collaboration led to the publication of an international patent application under the Patent Cooperation Treaty (PCT) [1].

The patent application covers an innovative combination therapy using Clearmind's proprietary 5-methoxy-2-aminoindane (MEAI) and SciSparc's Palmitoylethanolamide (PEA) for the treatment of metabolic syndrome and obesity. This combination therapy leverages PEA’s anti-inflammatory and neuroprotective properties alongside MEAI’s unique pharmacological profile to offer a potential safe and effective treatment for these widespread health challenges.

The collaboration between SciSparc and Clearmind has resulted in the filing of 13 patent families across multiple jurisdictions, including the United States, Europe, and China. The collaboration focuses on developing innovative therapies that combine neuroplastogens molecules with N-acylethanolamines, including PEA, to address mental health disorders such as depression and PTSD, addictions, and various metabolic conditions.

Despite the promising developments in the company's pipeline, the recent technical indicators suggest a bearish trend. The MACD Death Cross and Bearish Marubozu pattern indicate that the stock price may continue to decline, as sellers have gained control of the market. Investors should remain vigilant and consider the potential implications of these technical signals.

References:
[1] https://www.globenewswire.com/news-release/2025/08/07/3129137/0/en/SciSparc-Clearmind-Collaboration-Leads-to-Publication-of-International-Patent-Application-for-Novel-Combination-Therapy-Targeting-Obesity-and-High-Blood-Sugar.html